MX2019014671A - Contenedor con particulas para su uso con un inhalador. - Google Patents

Contenedor con particulas para su uso con un inhalador.

Info

Publication number
MX2019014671A
MX2019014671A MX2019014671A MX2019014671A MX2019014671A MX 2019014671 A MX2019014671 A MX 2019014671A MX 2019014671 A MX2019014671 A MX 2019014671A MX 2019014671 A MX2019014671 A MX 2019014671A MX 2019014671 A MX2019014671 A MX 2019014671A
Authority
MX
Mexico
Prior art keywords
container
particles
inhaler
microns
particle size
Prior art date
Application number
MX2019014671A
Other languages
English (en)
Spanish (es)
Inventor
Zuber Gerard
Waller Judith
Original Assignee
Philip Morris Products Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Philip Morris Products Sa filed Critical Philip Morris Products Sa
Publication of MX2019014671A publication Critical patent/MX2019014671A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A24TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24BMANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/10Chemical features of tobacco products or tobacco substitutes
    • A24B15/16Chemical features of tobacco products or tobacco substitutes of tobacco substitutes
    • AHUMAN NECESSITIES
    • A24TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24BMANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • AHUMAN NECESSITIES
    • A24TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24BMANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18Treatment of tobacco products or tobacco substitutes
    • A24B15/24Treatment of tobacco products or tobacco substitutes by extraction; Tobacco extracts
    • A24B15/241Extraction of specific substances
    • A24B15/243Nicotine
    • AHUMAN NECESSITIES
    • A24TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24BMANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18Treatment of tobacco products or tobacco substitutes
    • A24B15/28Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/30Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
    • A24B15/305Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances of undetermined constitution characterised by their preparation
    • A24B15/306Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances of undetermined constitution characterised by their preparation one reactant being an amino acid or a protein, e.g. Maillard's reaction
    • AHUMAN NECESSITIES
    • A24TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24BMANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18Treatment of tobacco products or tobacco substitutes
    • A24B15/28Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/30Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
    • A24B15/34Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances containing a carbocyclic ring other than a six-membered aromatic ring
    • AHUMAN NECESSITIES
    • A24TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24BMANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18Treatment of tobacco products or tobacco substitutes
    • A24B15/28Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/30Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
    • A24B15/36Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances containing a heterocyclic ring
    • A24B15/40Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances containing a heterocyclic ring having only oxygen or sulfur as hetero atoms
    • A24B15/403Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances containing a heterocyclic ring having only oxygen or sulfur as hetero atoms having only oxygen as hetero atoms
    • AHUMAN NECESSITIES
    • A24TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24FSMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
    • A24F40/00Electrically operated smoking devices; Component parts thereof; Manufacture thereof; Maintenance or testing thereof; Charging means specially adapted therefor
    • A24F40/20Devices using solid inhalable precursors
    • AHUMAN NECESSITIES
    • A24TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24FSMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
    • A24F40/00Electrically operated smoking devices; Component parts thereof; Manufacture thereof; Maintenance or testing thereof; Charging means specially adapted therefor
    • A24F40/40Constructional details, e.g. connection of cartridges and battery parts
    • A24F40/42Cartridges or containers for inhalable precursors
    • AHUMAN NECESSITIES
    • A24TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24FSMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
    • A24F42/00Simulated smoking devices other than electrically operated; Component parts thereof; Manufacture or testing thereof
    • A24F42/20Devices without heating means
    • AHUMAN NECESSITIES
    • A24TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24FSMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
    • A24F42/00Simulated smoking devices other than electrically operated; Component parts thereof; Manufacture or testing thereof
    • A24F42/60Constructional details
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0001Details of inhalators; Constructional features thereof
    • A61M15/0003Details of inhalators; Constructional features thereof with means for dispensing more than one drug
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0028Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/003Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0028Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/003Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
    • A61M15/0033Details of the piercing or cutting means
    • A61M15/0035Piercing means
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/06Inhaling appliances shaped like cigars, cigarettes or pipes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00Special media to be introduced, removed or treated
    • A61M2202/06Solids
    • A61M2202/064Powder
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2206/00Characteristics of a physical parameter; associated device therefor
    • A61M2206/10Flow characteristics
    • A61M2206/16Rotating swirling helical flow, e.g. by tangential inflows

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Otolaryngology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
MX2019014671A 2017-06-28 2018-06-26 Contenedor con particulas para su uso con un inhalador. MX2019014671A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP17178416 2017-06-28
PCT/IB2018/054720 WO2019003118A1 (en) 2017-06-28 2018-06-26 CONTAINER WITH PARTICLES FOR USE WITH INHALER

Publications (1)

Publication Number Publication Date
MX2019014671A true MX2019014671A (es) 2020-02-07

Family

ID=59253389

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019014671A MX2019014671A (es) 2017-06-28 2018-06-26 Contenedor con particulas para su uso con un inhalador.

Country Status (15)

Country Link
US (1) US12263242B2 (enExample)
EP (1) EP3644962A1 (enExample)
JP (2) JP2020527377A (enExample)
KR (2) KR20200023285A (enExample)
CN (2) CN110709063A (enExample)
AU (1) AU2018292732B2 (enExample)
BR (1) BR112019025635A2 (enExample)
CA (1) CA3061895A1 (enExample)
IL (1) IL269275B2 (enExample)
MX (1) MX2019014671A (enExample)
MY (1) MY200258A (enExample)
PH (1) PH12019502100A1 (enExample)
UA (1) UA126238C2 (enExample)
WO (1) WO2019003118A1 (enExample)
ZA (1) ZA201905999B (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109310622A (zh) * 2016-06-30 2019-02-05 菲利普莫里斯生产公司 尼古丁颗粒和组合物
EP3908133B1 (de) * 2019-01-07 2023-10-11 LuxCan Innovation S.A. Vorrichtung zum erzeugen eines gasförmigen wirkstoffs oder eines gasförmigen wirkstoffgemischs
JPWO2020189787A1 (enExample) * 2019-03-19 2020-09-24
EP3794996A1 (en) * 2019-09-20 2021-03-24 Nerudia Limited Smoking substitute apparatus
WO2021059094A1 (en) * 2019-09-26 2021-04-01 Philip Morris Products S.A. Inhaler article with a twisted distal end element
CN114554876B (zh) * 2019-11-14 2024-03-01 菲利普莫里斯生产公司 改进的烟草风味干粉制剂
CN116137819A (zh) * 2020-07-24 2023-05-19 菲利普莫里斯生产公司 吸入器制品
HUE072114T2 (hu) * 2020-09-03 2025-10-28 Philip Morris Products Sa Alacsony higroszkópikájú aktív porkészítmények
US12096803B2 (en) * 2020-11-04 2024-09-24 Anthony Hamilton E-cigarette vaporizer cartridge filling device
US20240017026A1 (en) * 2020-12-11 2024-01-18 Philip Morris Products, S.A. Inhaler system with single plane piercing element
JP2024529679A (ja) * 2021-08-19 2024-08-08 フィリップ・モーリス・プロダクツ・ソシエテ・アノニム 二つの粒子状材料を形成する固体の単一体の形態のエアロゾル形成基体
WO2023178643A1 (zh) * 2022-03-25 2023-09-28 云南中烟工业有限责任公司 一种不使用多通孔固件段的颗粒型气溶胶生成制品

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1242211A (en) * 1967-08-08 1971-08-11 Fisons Pharmaceuticals Ltd Pharmaceutical composition
US6234169B1 (en) 1998-08-14 2001-05-22 Arthur Slutsky Inhaler
US6766799B2 (en) 2001-04-16 2004-07-27 Advanced Inhalation Research, Inc. Inhalation device
JP2006513236A (ja) * 2002-12-31 2006-04-20 ネクター セラピューティクス 不溶性活性物質を伴う医薬製剤
EP1603615B1 (en) * 2003-03-20 2008-07-09 Galephar M/F Improved dry powder inhaler system
US8037880B2 (en) 2006-04-07 2011-10-18 The University Of Western Ontario Dry powder inhaler
NZ576637A (en) 2006-10-25 2012-05-25 Novartis Ag Powder dispersion apparatus with and mediciment receptacles that are cut open using an elliptical arc shaped knife blade oriented to yaw between 4 and 12 degrees
CN101888867B (zh) 2007-12-05 2013-05-15 诺瓦提斯公司 用于可雾化的药物制剂的容器
US8772886B2 (en) 2010-07-26 2014-07-08 Avalanche Technology, Inc. Spin transfer torque magnetic random access memory (STTMRAM) having graded synthetic free layer
ES2776003T3 (es) * 2011-05-27 2020-07-28 Boehringer Ingelheim Int Inhalador y cápsula para un inhalador
EP2614848B1 (de) * 2012-01-13 2020-07-01 Boehringer Ingelheim International GmbH Inhalator und Kapsel für einen Inhalator
EP2731572B1 (en) * 2011-07-13 2021-04-07 Pharmaxis Ltd. Improvements relating to delivery devices
US20140150787A1 (en) * 2012-12-04 2014-06-05 Civitas Therapeutics, Inc. Devices and methods for puncturing a capsule to release a powdered medicament therefrom
KR20170003926A (ko) * 2014-04-08 2017-01-10 산사 코포레이션 (바베이도스) 인코포레이티드 니코틴 제형 및 이의 제조방법
KR102428028B1 (ko) * 2014-04-28 2022-08-03 필립모리스 프로덕츠 에스.에이. 향미를 가진 니코틴 분말 흡입기
EP3157364B1 (en) 2014-06-20 2018-08-22 Philip Morris Products S.a.s. Nicotine powder delivery system with airflow management means
GB201411526D0 (en) * 2014-06-27 2014-08-13 British American Tobacco Co Powder
US11338099B2 (en) 2014-12-24 2022-05-24 Philip Morris Products S.A. Nicotine powder delivery system
US9585835B1 (en) 2015-09-16 2017-03-07 Sansa Corporation (Barbados) Inc. Inhalable nicotine formulations and methods of making and using the same
US10149844B2 (en) * 2015-09-16 2018-12-11 Philip Morris Products S.A. Inhalable nicotine formulations, and methods of making and using thereof
US11224594B2 (en) * 2015-09-16 2022-01-18 Philip Morris Products S.A. Nicotine formulations and methods of making and using the same
UA123586C2 (uk) * 2015-12-24 2021-04-28 Філіп Морріс Продактс С.А. Капсула із частинками нікотину
JP2019505479A (ja) * 2015-12-24 2019-02-28 フィリップ・モーリス・プロダクツ・ソシエテ・アノニム 風味付きニコチン粉末
CA3038252A1 (en) 2016-11-30 2018-06-07 Philip Morris Products S.A. Inhaler with swirl end plug

Also Published As

Publication number Publication date
KR20200023285A (ko) 2020-03-04
IL269275B2 (en) 2023-04-01
UA126238C2 (uk) 2022-09-07
CN117958505A (zh) 2024-05-03
JP2023078269A (ja) 2023-06-06
ZA201905999B (en) 2021-01-27
JP2020527377A (ja) 2020-09-10
RU2019141658A (ru) 2021-07-28
CN110709063A (zh) 2020-01-17
KR20240119177A (ko) 2024-08-06
BR112019025635A2 (pt) 2020-06-23
AU2018292732A1 (en) 2019-10-03
CA3061895A1 (en) 2019-01-03
PH12019502100A1 (en) 2020-03-16
IL269275B (en) 2022-12-01
EP3644962A1 (en) 2020-05-06
US12263242B2 (en) 2025-04-01
RU2019141658A3 (enExample) 2021-10-14
MY200258A (en) 2023-12-17
WO2019003118A1 (en) 2019-01-03
IL269275A (en) 2019-11-28
AU2018292732B2 (en) 2024-07-04
US20200196674A1 (en) 2020-06-25

Similar Documents

Publication Publication Date Title
MX2019014671A (es) Contenedor con particulas para su uso con un inhalador.
EA201591821A1 (ru) Защищенные от несанкционированного использования фармацевтические составы
BR112017012363A8 (pt) Microcápsulas revestidas, seu uso e produto de consumo que as compreende
CL2017002086A1 (es) Composición hemostática y dispositivo hemostático (variantes)
PH12018501199A1 (en) Nicotine particle capsule
CL2019001271A1 (es) Agentes de liberación de gas antimicrobianos y sistemas y métodos para utilizarlos
MX2016013156A (es) Dispositivos, sistemas y metodos fluidicos, para encapsular y dividir reactivos, y aplicaciones de los mismos.
EA201990525A3 (ru) Небулайзер и контейнер
AR104606A1 (es) Partícula recubierta
SG10201804931QA (en) Anti-cll-1 antibodies and immunoconjugates
MX2020003723A (es) Conjugados de farmaco-anticuerpo activable anti-cd71 y metodos de uso de estos.
WO2018156502A3 (en) Radiation activated gels that release fluids and assemblies containing the same
IT201700109512A1 (it) Sistema di aggancio, procedimento per la realizzazione dello stesso, uso di detto sistema di aggancio per la definizione di contenitori, buste, fasce ad evidenza di manomissione
CY1121991T1 (el) Εισπνευστηρας ξηρας κονεως και ενεργοποιουμενος με εισπνοη μηχανισμος αυτου
AR102683A1 (es) Composiciones de suministro de agente benéfico
CO2018006368A2 (es) Agente apuntalante de peso ligero y métodos para hacerlo y usarlo
CL2022000377A1 (es) Composiciones y partículas para la administración de carga útil
EP3702385A4 (en) CORE-ENVELOPE-TYPE PARTICLE, DISPERSION AND POWDER
MX381529B (es) Cierre de seguridad.
MX2021002053A (es) Productos que contienen cannabinoides, contenedores, sistemas y métodos.
MX2021005210A (es) Formulacion farmaceutica de complejo que comprende amlodipino, losartan y rosuvastatina.
SG10201901275PA (en) Storage device and server including the storage device
MX2016013967A (es) Pelicula biaxialmente orientada que tiene una capa porosa que contiene particulas.
MY199345A (en) Ceramic composite, phosphor for projector including the same, and light emitting device for projector including the same
IN2014DN10307A (enExample)